Miyake, Makito https://orcid.org/0000-0001-9503-7356
Nishimura, Nobutaka
Oda, Yuki
Shimizu, Takuto
Owari, Takuya
Iida, Kota
Nakai, Yasushi
Tanaka, Nobumichi
Fujimoto, Kiyohide
Funding for this research was provided by:
JSPS KAKENHI (23K08720)
Article History
Received: 23 September 2025
Accepted: 20 December 2025
First Online: 28 December 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nara Medical University (protocol IDs: NMU-1719 and NMU-2891).
: Written informed consent was obtained from all participants.
: K Fujimoto received honoraria from Merck Biopharma Co., Ltd., MSD K.K., and Ono pharmaceutical Co., Ltd.; received research funding from MSD K.K. and Ono pharmaceutical Co., Ltd.; served in a consulting or advisory role for Ono pharmaceutical Co., Ltd. The research funding from MSD K.K. and Ono pharmaceutical Co., Ltd. was not used for conducting the present study. M Miyake received honoraria from Merck Biopharma Co., Ltd., MSD K.K., and Ono pharmaceutical Co., Ltd.; served in a consulting or advisory role for Merck Biopharma Co., Ltd. and MSD K.K. Other authors disclose no potential conflicts of interest.